Maternal Metformin Treatment Reprograms Maternal High-Fat Diet-Induced Hepatic Steatosis in Offspring Associated with Placental Glucose Transporter Modifications
Open Access
- 17 November 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (22) , 14239
Abstract
Maternal high-fat (HF) diet exposure in utero may affect fetal development and cause metabolic problems throughout life due to lipid dysmetabolism and oxidative damage. Metformin has been suggested as a potential treatment for body weight reduction and nonalcoholic fatty liver disease, but its reprogramming effect on offspring is undetermined. This study assesses the effects of maternal metformin treatment on hepatic steatosis in offspring caused by maternal HF diet. Female rats were fed either a control or an HF diet before conception, with or without metformin treatment during gestation, and placenta and fetal liver tissues were collected. In another experiment, the offspring were fed a control diet until 120 d (adult stage). Metformin treatment during pregnancy ameliorates placental oxidative stress and enhances placental glucose transporter 1 (GLUT1), GLUT3, and GLUT4 expression levels through 5’ adenosine monophosphate-activated protein kinase (AMPK) activation. Maternal metformin treatment was shown to reprogram maternal HF diet-induced changes in offspring fatty liver with the effects observed in adulthood as well. Further validation is required to develop maternal metformin therapy for clinical applications.Keywords
Funding Information
- Chang Gung Memorial Hospital (CMRPG8L1031, CMRPG 8J0872, CMRPG8L1541, CMRPG8M0391, 111-2314-B-182-044)
- Ministry of Science and Technology (CMRPG8L1031, CMRPG 8J0872, CMRPG8L1541, CMRPG8M0391, 111-2314-B-182-044)
This publication has 45 references indexed in Scilit:
- Maternal obesity and high-fat diet program offspring metabolic syndromeAmerican Journal of Obstetrics and Gynecology, 2014
- Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013The Lancet, 2014
- Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: A systematic reviewMetabolism, 2013
- Review of article: Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010 by Katherine M. Flegal, PhD; Margaret D. Carroll, MSPH; Brian K. Kit, MD; Cynthia L. Ogden, PhD (JAMA 2012;307:491-7)Journal of Vascular Nursing, 2013
- Impact of Maternal Obesity on Fetal HealthFetal Diagnosis and Therapy, 2013
- Metformin augments the levels of molecules that regulate the expression of the insulin-dependent glucose transporter GLUT4 in the endometria of hyperinsulinemic PCOS patientsHuman Reproduction, 2013
- Mechanisms of metformin action on glucose transport and metabolism in human adipocytesBiochemical Pharmacology, 2010
- Glucose transporters in the 21st CenturyAmerican Journal of Physiology-Endocrinology and Metabolism, 2010
- Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndromeEuropean Journal of Endocrinology, 2010
- Glucose transporter isoform 4 is expressed in the syncytiotrophoblast of first trimester human placentaHuman Reproduction, 2005